Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRecord History shows a new revision labeled v3.5.3, replacing the previous v3.5.2. This represents a minor update to the page's revision metadata rather than substantive changes to the study record.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision v3.5.2 was added to the history. Revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision history now shows a new entry v3.4.3 and removes v3.4.2 from the record.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added to the Record History. The deletions remove a government-funding notice and the earlier Revision: v3.4.1 from the history.SummaryDifference0.8%

- Check98 days agoChange DetectedA government funding notice was added at the top of the page, and a new release note 'Revision: v3.4.1' was posted. The previous release note 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.